| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.92B | 101.01B | 92.33B | 94.51B | 76.09B | 62.85B |
| Gross Profit | 22.40B | 21.26B | 17.92B | 19.21B | 17.98B | 14.96B |
| EBITDA | 6.10B | 5.63B | 3.06B | 5.22B | 5.44B | 4.93B |
| Net Income | 791.00M | 763.00M | -1.16B | 885.73M | 1.75B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 101.00B | 100.04B | 98.58B | 92.44B | 78.91B | 69.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 4.75B | 6.85B | 6.30B | 6.63B | 3.48B |
| Total Debt | 42.03B | 42.56B | 39.37B | 33.67B | 21.50B | 17.68B |
| Total Liabilities | 64.06B | 62.03B | 57.70B | 51.62B | 38.80B | 31.95B |
| Stockholders Equity | 36.27B | 37.33B | 37.22B | 37.10B | 36.74B | 34.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 684.00M | -3.08B | -4.80B | -22.99M | 712.74M |
| Operating Cash Flow | 0.00 | 6.14B | 353.00M | -466.24M | 2.83B | 3.01B |
| Investing Cash Flow | 0.00 | -4.98B | -3.20B | -6.65B | -3.44B | -1.86B |
| Financing Cash Flow | 0.00 | -3.67B | 2.90B | 7.66B | 2.11B | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥38.78B | 17.48 | ― | 2.47% | 3.53% | 8.36% | |
77 Outperform | ¥28.41B | 17.43 | ― | 3.63% | 18.02% | 18.04% | |
76 Outperform | ¥28.43B | 10.86 | ― | 3.21% | 9.61% | 173.72% | |
72 Outperform | ¥30.67B | 14.88 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥25.34B | 13.28 | ― | 4.62% | 7.19% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥28.95B | 16.95 | ― | 4.27% | 5.72% | 28.92% |
Harima Chemicals Group has agreed to sell its shareholding in Swedish company SunPine AB, currently held indirectly through its subsidiary Lawter Europe BV, to existing shareholder Preem, also of Sweden. Harima originally invested in SunPine in 2012 to secure stable European supplies of tall oil rosin, but a prolonged decline in rosin demand has eased supply-demand pressures, and long-term purchase contracts with SunPine mean the divestment is not expected to disrupt its raw material procurement.
The company expects no impact on its consolidated financial results for fiscal 2025, while the effect on fiscal 2026 earnings remains under review and will be disclosed if material. Proceeds from the transaction will be directed toward capital investments in growth areas and debt reduction, signaling a strategic reallocation of assets to strengthen Harima’s balance sheet and support future expansion despite weakness in the rosin market.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen1043.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.
Harima Chemicals Group has decided to sell its entire 24.6% stake in Swedish joint venture SunPine AB, held via Lawter Europe BV, to existing shareholder VAROPreem AB, Sweden’s largest fuel refining and sales company, and is now negotiating final contract terms. The divestment is aimed at improving capital efficiency by monetizing policy‑held shares and reallocating capital to growth areas, while Harima expects no disruption to its tall oil rosin procurement or to FY2025 results, reflecting a response to easing rosin demand and a shift in portfolio strategy.
SunPine has supplied Harima with tall oil rosin under long‑term contracts, and these arrangements are expected to remain in place despite the ownership change, underscoring that the move is a financial and strategic rebalancing rather than an operational retreat. The decision follows Preem’s exercise of its preferential right to acquire the shares on terms equivalent to an external investor’s offer, consolidating SunPine’s ownership among Swedish partners as Harima reviews the potential impact on FY2026 earnings and refocuses capital on higher‑growth segments.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen1056.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.
Harima Chemicals Group has revised its fiscal 2025 consolidated earnings forecast, leaving net sales unchanged at ¥108 billion but substantially raising profit projections, with operating income expected to rise to ¥3.3 billion, ordinary income to ¥2.8 billion, and net income attributable to the parent to ¥1.85 billion. The company cited stronger-than-expected performance in its Resins and Tall Oil Products business driven by new paint resin products, as well as robust demand in its Electronic Materials division for resins used in semiconductor resists, offsetting weaker sales in Paper Chemicals in Japan and China and lower-than-anticipated volumes in the Lawter business due to a sluggish recovery in Europe and the U.S.; as a result, profitability is now forecast to grow significantly year on year, signaling improved earnings efficiency despite flat overall sales.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen1008.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.
Harima Chemicals Group reported steady topline growth and sharply improved profitability for the third quarter of the fiscal year ending March 31, 2026, with net sales up 2.9% year on year to ¥77.9 billion and net income attributable to the parent more than doubling, rising 149.2% to ¥1.8 billion. Operating income climbed 36.8% to ¥2.7 billion and ordinary income rose 63.5%, while total assets increased to ¥103.3 billion and equity also improved, indicating a stronger balance sheet. The company maintained its interim dividend at ¥21 per share and kept the full-year dividend forecast at ¥42, and it upgraded its full-year earnings outlook, now projecting net sales of ¥108 billion and a 142.5% jump in full-year net income to ¥1.85 billion, signaling improved operational efficiency and a more optimistic earnings trajectory for shareholders despite only modest sales growth. The consolidation scope, accounting policies, and capital structure remained largely unchanged, underscoring that the performance improvement is driven primarily by core operations rather than structural changes.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen1008.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.
Harima Chemicals Group, Inc. announced changes in its senior personnel, effective January 1, 2026, following a Board of Directors’ meeting. These changes include new appointments for key positions within the company, which may influence its strategic direction and operational efficiency, particularly in its paper chemicals division.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen951.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.